Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-2 of 2
Keywords: urocortin 2
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Theophilus I. Emeto, Joseph V. Moxon, Erik Biros, Catherine M. Rush, Paula Clancy, Lynn Woodward, Corey S. Moran, Roby J. Jose, Tam Nguyen, Philip J. Walker, Jonathan Golledge
Journal:
Clinical Science
Clin Sci (Lond) (2014) 126 (7): 517–527.
Published: 11 December 2013
... pathology [ 20 ]. There are no current effective drug therapies for abdominal aortic aneurysm, an important cause of death in older adults. Our study suggests that urocortin 2 participates in the disease process and may serve as a putative therapeutic target. aneurysm corticotrophin releasing...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2008) 114 (10): 635–642.
Published: 14 April 2008
...Miriam T. Rademaker; Christopher J. Charles; M. Gary Nicholls; A. Mark Richards Ucn2 (urocortin 2) is a recently discovered peptide with therapeutic potential in heart failure. As any new treatment is likely to be used in conjunction with standard ACEI (angiotensin-converting enzyme inhibitor...
